A Study to Assess the Effectiveness and Safety of Clonidine Extended-Release OnydaTM XR in Children With ADHD and ODD

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

162

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Attention-deficit/Hyperactivity DisorderOppositional Defiant Disorder in Children

Interventions

DRUG

Clonidine extended release oral suspension

The study is blinded and the active clonidine extended-release oral suspension will look just like the placebo comparator.

DRUG

Placebo

Placebo suspension

All Listed Sponsors

collaborator

Tris Pharma, Inc.

INDUSTRY

lead

Las Vegas Medical Research, LLC DBA Vector Clinical Trials

OTHER